Open AccessMultisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes
Author(s) -
Mary Beth F. Son,
Nancy L. Murray,
Kevin G. Friedman,
Cameron C. Young,
Margaret M. Newhams,
Leora R. Feldstein,
Laura L. Loftis,
Keiko M. Tarquinio,
Aalok R. Singh,
Sabrina M. Heidemann,
Vijaya L Soma,
Becky J. Riggs,
Julie C. Fitzgerald,
Michele Kong,
Sule Doymaz,
John S. Giuliano,
Michael Keenaghan,
Janet R. Hume,
Charlotte V. Hobbs,
Jennifer E. Schuster,
Katharine N. Clouser,
Mark W. Hall,
Lincoln Smith,
Steven M. Horwitz,
Stephanie P. Schwartz,
Katherine Irby,
Tamara T. Bradford,
Aline B. Maddux,
Christopher J. Babbitt,
Courtney M. Rowan,
Gwenn E. McLaughlin,
Phoebe H. Yager,
Mia Maamari,
Elizabeth H. Mack,
Christopher L. Carroll,
Vicki Montgomery,
Natasha Halasa,
Natalie Z. Cvijanovich,
Bria M. Coates,
Charles E. Rose,
Jane W. Newburger,
Manish M. Patel,
Adrienne G. Randolph
Publication year - 2021
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2102605
Subject(s) - medicine , intensive care medicine
The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom